...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AMONG PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA POST STATIN THERAPY

【24h】

LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AMONG PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA POST STATIN THERAPY

机译：低密度脂蛋白胆固醇水平在患有临床动脉粥样硬化性心血管疾病和杂合性家族性高胆固醇血症的患者中，他汀类药物治疗后的水平

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第3期|共1页
作者
Johnson B. H.; Bonafede M. M.; Princic N.; Harrison D. J.; Boatman B.; Patel J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AMONG PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA POST STATIN THERAPY [J] . Johnson B. H., Bonafede M. M., Princic N., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第3期

机译：低密度脂蛋白胆固醇水平在患有临床动脉粥样硬化性心血管疾病和杂合性家族性高胆固醇血症的患者中，他汀类药物治疗后的水平
2. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia. [J] . Miltiadous G, Saougos V, Cariolou M, Annals of Clinical and Laboratory Science: Official Journal of the Association of Clinical Scientists . 2006,第3期

机译：杂合性家族性高胆固醇血症患者对他汀类药物治疗的血浆脂蛋白（a）水平和LDL-胆固醇降低反应。
3. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: The reduction of LDL-C with PCSK9 inhibition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) randomized trial [J] . RaalF., ScottR., SomaratneR., Circulation: An Official Journal of the American Heart Association . 2012,第20期

机译：AMG 145的低密度脂蛋白胆固醇降低作用，对杂合子家族性高胆固醇血症患者的前蛋白转化酶枯草杆菌蛋白酶/ kexin 9型丝氨酸蛋白酶的单克隆抗体：PCSK9抑制可降低LDL-C对杂合子家族性高胆固醇血症（RUTHERFORD）的影响试用
4. Plasma levels of SCD40L are associated with HDL-cholesterol and apoA-1 in patients with clinical diagnosis of familial hypercholesterolemia (FH). [C] . Idzior-Walus B., Hubalewska-Dydejczyk A., Walus-Miarka M., International Congress on Coronary Artery Disease . 2009

机译：SCD40L的血浆水平与家族性高胆固醇血症（FH）临床诊断患者的HDL-胆固醇和APOA-1相关。
5. Influence of the demographic factors and clinical variation on the low-density lipoprotein level among low income patients with cardiovascular conditions in San Diego County. [D] . Ali, Abdinasir Kaysane. 2014

机译：人口统计学因素和临床变异对圣地亚哥县低收入心血管疾病患者低密度脂蛋白水平的影响。
6. Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients [O] . Chi-Chang Chen, Pallavi B Rane, Dionne M Hines, 2018

机译：在非PCSK9i降脂治疗后的低密度脂蛋白胆固醇结局在动脉粥样硬化性心血管疾病和可能的杂合性家族性高胆固醇血症患者中
7. low Density Lipoprotein Cholesterol Levels Among Patients with Clinical Atherosclerotic Cardiovascular Disease and Heterozygous Familial Hypercholesterolemia Post Statin Therapy [O] . BH Johnson, MM Bonafede, N Princic, 2016

机译：低密度脂蛋白胆固醇水平患者临床动脉粥样硬脑膜疾病和杂合族家族性高胆固醇血症后他汀类药物治疗

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号